Site icon IAS Current Affairs

Oropouche Virus (OROV)

Oropouche Virus (OROV)

Image by Miku Aalto from Pixabay

Oropouche Virus (OROV)

Source: News Medical
GS II: Issues relating to the development and management of Social Sector/Services relating to Health, Education, Human Resources


Overview

  1. Details of Oropouche Virus (OROV)

Why in the News?

In a recent study published in the journal Emerging Infectious Diseases, researchers, investigated the presence of replication-competent Oropouche virus (OROV) (an arbovirus causing flu-like illness, transmitted by biting midges and mosquitoes) in the semen of a traveler diagnosed with Oropouche fever, highlighting potential risks for sexual transmission.

Details of Oropouche Virus (OROV)

  • Oropouche virus (OROV) belongs to the Simbu serogroup of the viral genus Orthobunyavirus in the Peribunyaviridae family.
  • It was first detected in 1955 in Trinidad and Tobago, near the Oropouche River, where a febrile forest worker fell ill.

1. Transmission and Reservoirs:

  • OROV is primarily spread by infected biting midges (Culicoides species) and, to a lesser extent, mosquitoes.
  • Natural reservoirs include sloths, non-human primates, and birds.

2. Clinical Presentation:

  • Oropouche fever typically manifests as follows:
    • Abrupt Onset: Patients experience sudden fever (38-40°C), severe headache, chills, myalgia, and arthralgia.
    • Similar to Other Arboviruses: Clinical features often mimic dengue, chikungunya, Zika viruses, or malaria.
    • Rash and Other Symptoms: Photophobia, dizziness, eye pain, nausea, vomiting, and a maculopapular rash (starting on the trunk and extending to extremities).
    • Recurrent Symptoms: In up to 60% of cases, symptoms may reoccur a few days or weeks later.

3. Epidemiology:

  • OROV is endemic to the Amazon basin.
  • Prior to 2000, outbreaks occurred in Brazil, Panama, and Peru.
  • Recent cases have been identified in Argentina, Bolivia, Colombia, Ecuador, French Guiana, Panama, and Peru.
  • In June 2024, Cuba reported its first confirmed Oropouche case.

4. Diagnosis and Treatment:

  • No specific vaccines or antiviral medicines exist for OROV.
  • Diagnosis relies on clinical presentation, travel history, and laboratory findings (lymphopenia, leukopenia, elevated CRP, and mild liver enzyme elevation).
  • Supportive care is essential.

5. Prevention:

  • Personal protective measures (avoiding bites) remain crucial.
  • Currently, there is no evidence of local transmission in the United States.

In summary, Oropouche virus poses a significant public health challenge, especially in endemic regions. Vigilance, research, and international cooperation are essential to combat this emerging arbovirus. 


Daily Current Affairs: Click Here

Rate this Article and Leave a Feedback
Exit mobile version